Methyl 5-bromo-4-pyrimidinecarboxylate, 95.0%, 250mg

2-(2-((tert-Butoxycarbonyl)amino)phenyl)acetic acid, 95.0%, 10g

Di(pyridin-4-yl)methanone, 95.0%, 1g

1-(2,5-Dihydro-1H-pyrrol-1-yl)-2,2-dimethylpropan-1-one, 97%, 5g

2-(4,7-Bis(2-(tert-butoxy)-2-oxoethyl)-1,4,7-triazonan-1-yl)acetic acid, 97%, 50mg

8-(4-Isopropylpyridin-2-yl)-2-methylbenzofuro[2,3-b]pyridine, 97%, 250mg

1-ALLYL 4-TERT-BUTYL PIPERAZINE-1,4-DICARBOXYLATE, 95.0%, 5g

Monomethacryloxypropyl functional poldimethylsiloxanes methoxypropyl terminated symmetric 8-12cSt, 100g

2-(3-Ethoxy-4-(ethoxycarbonyl)phenyl)acetic acid, 95.0%, 1g

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole, 97%, 1g

Tert-butyln-(6-bromo-2,3-dihydrobenzofuran-3-yl)carbamate, 98+%, 1g

Methyl DL-2-(1-Boc-piperidin-4-yl)-beta-glycinate, 97.0%, 250mg

2,4,6-Tri(pyridin-4-yl)pyridine>98.0%(HPLC)(N)1g